The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials
<h3>Background</h3><p dir="ltr"><u>Metabolic syndrome</u> (MetS) is a chronic disorder featuring overweight/obesity, high blood pressure, and dysfunction of lipid and <u>carbohydrate metabolism</u>. Microbiome-modulating<u> probiotics, prebio...
محفوظ في:
| المؤلف الرئيسي: | Ridhima Kaul (12485902) (author) |
|---|---|
| مؤلفون آخرون: | Pradipta Paul (12628162) (author), Manale Harfouche (4557211) (author), Muhammad Ayyan (16328986) (author), Sa'ad Laws (19772763) (author), Ali Chaari (827168) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials
حسب: Ridhima Kaul (12485902)
منشور في: (2023) -
The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials
حسب: Pradipta Paul (12628162)
منشور في: (2022) -
Can the Salivary Microbiome Predict Cardiovascular Diseases? Lessons Learned From the Qatari Population
حسب: Selvasankar Murugesan (4376506)
منشور في: (2021) -
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
حسب: Farhan, Cyprian
منشور في: (2021) -
Primary immunodeficiency and the microbiome
حسب: Maryam Ali Al-Nesf (16328649)
منشور في: (2021)